Vaccine Industry Growing Amid Increased Funding, Higher Profits
Main Category: Immune System / VaccinesAlso Included In: Seniors / Aging; Flu / Cold / SARS
Article Date: 31 Jan 2007 - 1:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
The Los Angeles Times on Sunday examined "a boom in vaccine discovery and development" prompted by advances in technology, "increased funding and higher profits." In 2006, vaccine manufacturers introduced new vaccines for human papillomavirus, rotavirus and shingles among elderly patients. "As early as the end of the decade, scientists say, there may be new immunizations against herpes simplex and rheumatoid arthritis and a better seasonal flu vaccine," the Times reports. Scientists also are "talking about a potential vaccine within five years to fight malaria," according to the Times. Large pharmaceutical companies such as GlaxoSmithKline, Novartis and Pfizer recently have indicated increased interest in development of new vaccines through billions of dollars spent on acquisitions of smaller vaccine manufacturers and expansion of research programs. GSK Biologicals President Jean Stephenne said that he expects the company to introduce five new vaccines within five years and that vaccines will account for 14% of sales by 2010, compared with 6% in 2007. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at NIH, said, "It's clear there is a renaissance going on around vaccines. We have made more progress with some (vaccines) in the past few years than we have in the past 30." However, experts said that advances in the development of new vaccines "could stall at any time, and several promising vaccine candidates remain in early clinical trials," the Times reports (Los Angeles Times, 1/28).
"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our immune system / vaccines section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/61874.php>
APA
http://www.medicalnewstoday.com/releases/61874.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



